Breaking News Instant updates and real-time market news.

NKTR

Nektar

$33.07 /

-0.4 (-1.20%)

05:45
05/24/19
05/24
05:45
05/24/19
05:45

Mizuho reiterates $81 price target on Nektar after management meetings

Mizuho analyst Difei Yang reiterates a Buy rating on Nektar Therapeutics with an $81 price target after hosting investor meetings with management. Investors remain focused on NKTR-214, says the analyst, who remains encouraged by the available data to date from Pivot across several indications. Yang admits, however, that Phase III readouts will be needed to confirm her view on NKTR-214. In the meantime, the upcoming data updates at ASCO for melanoma and ESMO for non-small-cell lung carcinoma could be catalysts for Nektar shares, Yang tells investors in a research note.

  • 31

    May

  • 12

    Jun

NKTR Nektar
$33.07 /

-0.4 (-1.20%)

02/21/19 BMOC
Nektar initiated with an Outperform at BMO Capital
03/01/19 PIPR
Nektar price target lowered to $100 from $125 at Piper Jaffray
03/15/19 LEER
Nektar initiated with a Market Perform at SVB Leerink
05/09/19 PIPR
Nektar update at ASCO likely to be positive, says Piper Jaffray

TODAY'S FREE FLY STORIES

Downgrade
Shenandoah shares fairly valued, says Raymond James » 07:40
01/27/20
01/27
07:40
01/27/20
07:40
SHEN

Shenandoah

$44.26 /

-0.12 (-0.27%)

Raymond James analyst Ric…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Apple Q1 estimates are 'reasonable', says RBC Capital » 07:39
01/27/20
01/27
07:39
01/27/20
07:39
AAPL

Apple

/

+

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Xerox resumed with an Equal Weight at Morgan Stanley » 07:39
01/27/20
01/27
07:39
01/27/20
07:39
XRX

Xerox

$35.52 /

-0.71 (-1.96%)

, HPQ

HP Inc.

$21.99 /

-0.115 (-0.52%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
CenterState Bank reports Q4 non-GAAP EPS 57c, consensus 52c » 07:38
01/27/20
01/27
07:38
01/27/20
07:38
CSFL

CenterState Bank

$23.32 /

-0.45 (-1.89%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Synovus downgraded to Outperform from Strong Buy at Raymond James » 07:38
01/27/20
01/27
07:38
01/27/20
07:38
SNV

Synovus

$36.66 /

-2.77 (-7.03%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
CenterState Bank, South State combine in all-stock merger » 07:37
01/27/20
01/27
07:37
01/27/20
07:37
CSFL

CenterState Bank

$23.32 /

-0.45 (-1.89%)

, SSB

South State

$85.57 /

-0.64 (-0.74%)

CenterState Bank (CSFL)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Investors to focus on Tesla's 2020 delivery guidance, says Oppenheimer » 07:37
01/27/20
01/27
07:37
01/27/20
07:37
TSLA

Tesla

$564.89 /

-7.085 (-1.24%)

Ahead of Tesla quarterly…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
South State reports Q4 EPS $1.48, consensus $1.43 » 07:35
01/27/20
01/27
07:35
01/27/20
07:35
SSB

South State

$85.57 /

-0.64 (-0.74%)

Reports Q4 book value per…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Unusual call flow in option market yesterday » 07:35
01/27/20
01/27
07:35
01/27/20
07:35
INTC

Intel

$68.47 /

+5.15 (+8.13%)

Notable call activity was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
NCC Group downgraded to Hold from Buy at Berenberg » 07:33
01/27/20
01/27
07:33
01/27/20
07:33
NCCGF

NCC Group

$0.00 /

+ (+0.00%)

Berenberg analyst Edward…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Guggenheim has high conviction in MyoKardia trial after cardiologist survey » 07:32
01/27/20
01/27
07:32
01/27/20
07:32
MYOK

MyoKardia

$69.02 /

-0.87 (-1.24%)

Following a survey of 80…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Macatawa Bank raises quarterly dividend 14% to 8c per share » 07:31
01/27/20
01/27
07:31
01/27/20
07:31
MCBC

Macatawa Bank

$10.85 /

+0.19 (+1.78%)

Macatawa Bank announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Upgrade
S&P Global upgraded to Outperform from Market Perform at BMO Capital » 07:31
01/27/20
01/27
07:31
01/27/20
07:31
SPGI

S&P Global

$294.82 /

-2.51 (-0.84%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Estee Lauder downgraded to Perform on near-term risks at Oppenheimer » 07:30
01/27/20
01/27
07:30
01/27/20
07:30
EL

Estee Lauder

$205.32 /

-3.47 (-1.66%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
IHS Markit downgraded to Market Perform from Outperform at BMO Capital » 07:26
01/27/20
01/27
07:26
01/27/20
07:26
INFO

IHS Markit

$79.89 /

-0.7 (-0.87%)

, SPGI

S&P Global

$294.82 /

-2.51 (-0.84%)

, MCO

Moody's

$255.58 /

-1.47 (-0.57%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Google 'an excellent' partner for Activision infrastructure needs, says KeyBanc » 07:26
01/27/20
01/27
07:26
01/27/20
07:26
ATVI

Activision Blizzard

$59.36 /

-0.77 (-1.28%)

, GOOG

Alphabet

$1,466.47 /

-19.67 (-1.32%)

, GOOGL

Alphabet Class A

$1,465.80 /

-19.06 (-1.28%)

, AMZN

Amazon.com

$1,862.09 /

-22.76 (-1.21%)

KeyBanc analyst Tyler…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Intel shares have 'chicken or egg' problem, says Northland » 07:23
01/27/20
01/27
07:23
01/27/20
07:23
INTC

Intel

$68.47 /

+5.15 (+8.13%)

Northland analyst Gus…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
S&P Global upgraded to Outperform from Market Perform at BMO Capital » 07:22
01/27/20
01/27
07:22
01/27/20
07:22
SPGI

S&P Global

$294.82 /

-2.51 (-0.84%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Chewy upgraded to Outperform at Wedbush on online pet industry sales growth » 07:21
01/27/20
01/27
07:21
01/27/20
07:21
CHWY

Chewy

$28.48 /

+0.41 (+1.46%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
IHS Markit downgraded to Market Perform from Outperform at BMO Capital » 07:20
01/27/20
01/27
07:20
01/27/20
07:20
INFO

IHS Markit

$79.89 /

-0.7 (-0.87%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Intelligent Systems initiated with a Buy at BTIG » 07:19
01/27/20
01/27
07:19
01/27/20
07:19
INS

Intelligent Systems

$40.39 /

+0.35 (+0.87%)

, AAPL

Apple

$318.25 /

-1.02 (-0.32%)

BTIG analyst Mark Palmer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Halozyme price target raised to $35 from $27 at Cantor Fitzgerald » 07:18
01/27/20
01/27
07:18
01/27/20
07:18
HALO

Halozyme

$19.07 /

-0.58 (-2.95%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Sorrento Therapeutics to present clinical trial data for resiniferatoxin » 07:18
01/27/20
01/27
07:18
01/27/20
07:18
SRNE

Sorrento Therapeutics

$4.29 /

+0.105 (+2.51%)

Sorrento Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Target 12% pullback 'key buying opportunity,' says JPMorgan » 07:16
01/27/20
01/27
07:16
01/27/20
07:16
TGT

Target

$114.31 /

-1.23 (-1.06%)

JPMorgan analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
RedHill Biopharma on track to launch Talicia in the U.S. in 1Q20 » 07:15
01/27/20
01/27
07:15
01/27/20
07:15
RDHL

RedHill Biopharma

$5.96 /

-0.045 (-0.75%)

RedHill Biopharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.